Loh H, Mahfut F, Chen S, Huang Y, Huo J, Zhang W, et al. Manufacturability and functionality assessment of different formats of T-cell engaging bispecific antibodies. MAbs. 2023;15:2231129 pubmed publisher

Leland P, Kumar D, Nimmagadda S, Bauer S, Puri R, Joshi B. Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging. J Transl Med. 2023;21:367 pubmed publisher

McKenzie C, El Kholy M, Parekh F, Robson M, Lamb K, Allen C, et al. Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy. Mol Ther Nucleic Acids. 2023;32:603-621 pubmed publisher

Bigenwald C, Haddad Y, Thelemaque C, Carrier A, Birebent R, Ly P, et al. RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies. Oncoimmunology. 2023;12:2163785 pubmed publisher

Madison B, Patil D, Richter M, Li X, Tong M, Cranert S, et al. Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells. Mol Ther Nucleic Acids. 2022;29:979-995 pubmed publisher

Scurr M, Lippiatt G, Capitani L, Bentley K, Lauder S, Smart K, et al. Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity. Nat Commun. 2022;13:5422 pubmed publisher

Hirschberger S, Gellert L, Effinger D, Muenchhoff M, Herrmann M, Briegel J, et al. Ketone Bodies Improve Human CD8+ Cytotoxic T-Cell Immune Response During COVID-19 Infection. Front Med (Lausanne). 2022;9:923502 pubmed publisher

Shemesh A, Pickering H, Roybal K, Lanier L. Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion. J Exp Med. 2022;219: pubmed publisher

Singhal J, Madan E, Chaurasiya A, Srivastava P, Singh N, Kaushik S, et al. Host SUMOylation Pathway Negatively Regulates Protective Immune Responses and Promotes Leishmania donovani Survival. Front Cell Infect Microbiol. 2022;12:878136 pubmed publisher

Singh S, Chauhan S, Ng S, Corvino D, de Labastida Rivera F, Engel J, et al. Increased amphiregulin expression by CD4+ T cells from individuals with asymptomatic Leishmania donovani infection. Clin Transl Immunology. 2022;11:e1396 pubmed publisher

Iraqi M, Edri A, Greenshpan Y, Goldstein O, Ofir N, Bolel P, et al. Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma. Int J Mol Sci. 2022;23: pubmed publisher

Kofla G, Radecke C, Frentsch M, Walther W, Stintzing S, Riess H, et al. Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade. Oncoimmunology. 2022;11:2068109 pubmed publisher

Labanieh L, Majzner R, Klysz D, Sotillo E, Fisher C, Vilches Moure J, et al. Enhanced safety and efficacy of protease-regulated CAR-T cell receptors. Cell. 2022;185:1745-1763.e22 pubmed publisher

Sheng Y, Hu W, Shen H, Wei C, Liu Y, Ma X, et al. An imbalance of the IL-33/ST2-AXL-efferocytosis axis induces pregnancy loss through metabolic reprogramming of decidual macrophages. Cell Mol Life Sci. 2022;79:173 pubmed publisher

Lei W, Ye Q, Hao Y, Chen J, Huang Y, Yang L, et al. CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma. Blood Cancer J. 2022;12:35 pubmed publisher

Feng Y, Xie K, Yin Y, Li B, Pi C, Xu X, et al. A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity. Life (Basel). 2022;12: pubmed publisher

Liu C, Liu W, Ma H, Chen Y, Hueng D, Tsai W, et al. Interstitial Control-Released Polymer Carrying a Targeting Small-Molecule Drug Reduces PD-L1 and MGMT Expression in Recurrent High-Grade Gliomas with TMZ Resistance. Cancers (Basel). 2022;14: pubmed publisher

Booty M, Hlavaty K, Stockmann A, Ozay E, Smith C, Tian L, et al. Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor Activity. J Immunol. 2022;208:929-940 pubmed publisher

Heitzeneder S, Bosse K, Zhu Z, Zhelev D, Majzner R, Radosevich M, et al. GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity. Cancer Cell. 2022;40:53-69.e9 pubmed publisher

Wang H, Chen H, Liu S, Zhang J, Lu H, Somasundaram R, et al. Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function. J Immunother Cancer. 2021;9: pubmed publisher

Pires D, Calado M, Velez T, Mandal M, Catalão M, Neyrolles O, et al. Modulation of Cystatin C in Human Macrophages Improves Anti-Mycobacterial Immune Responses to Mycobacterium tuberculosis Infection and Coinfection With HIV. Front Immunol. 2021;12:742822 pubmed publisher

Cordoba S, Onuoha S, Thomas S, Pignataro D, Hough R, Ghorashian S, et al. CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial. Nat Med. 2021;27:1797-1805 pubmed publisher

Sp N, Kang D, Lee J, Jang K. Mechanistic Insights of Anti-Immune Evasion by Nobiletin through Regulating miR-197/STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer (NSCLC) Cells. Int J Mol Sci. 2021;22: pubmed publisher

Hirschberger S, Strauß G, Effinger D, Marstaller X, Ferstl A, Müller M, et al. Very-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming. EMBO Mol Med. 2021;13:e14323 pubmed publisher

You Y, Huang S, Liu H, Fan C, Liu K, Wang Z. Soluble fibrinogen‑like protein 2 levels are decreased in patients with ischemic heart failure and associated with cardiac function. Mol Med Rep. 2021;24: pubmed publisher

Pires D, Valente S, Calado M, Mandal M, Azevedo Pereira J, Anes E. Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection. Front Immunol. 2021;12:647728 pubmed publisher

Xie X, Chen C, Chen W, Jiang J, Wang L, Li T, et al. Structural Basis of VSIG3: The Ligand for VISTA. Front Immunol. 2021;12:625808 pubmed publisher

Kang C, Kim Y, Lee H, Lee S, Jeong H, Choi S, et al. Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line. Int J Mol Sci. 2020;21: pubmed publisher

Fernandes R, Su L, Nishiga Y, Ren J, Bhuiyan A, Cheng N, et al. Immune receptor inhibition through enforced phosphatase recruitment. Nature. 2020;586:779-784 pubmed publisher

Pierini S, Tanyi J, Simpkins F, George E, Uribe Herranz M, Drapkin R, et al. Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. JCI Insight. 2020;5: pubmed publisher

Lucchesi D, Coleby R, Pontarini E, Prediletto E, Rivellese F, Hill D, et al. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome. Arthritis Rheumatol. 2020;72:1559-1570 pubmed publisher

Leung E, Ennis D, Kennedy P, Hansell C, Dowson S, Farquharson M, et al. NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer. Mol Ther Oncolytics. 2020;16:289-301 pubmed publisher

Wu Z, Subramanian N, Jacobsen E, Laib Sampaio K, van der Merwe J, Hönig M, et al. NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV. Microorganisms. 2019;7: pubmed publisher

Oll Hurtado M, Wolbert J, Fisher J, Flutter B, Stafford S, Barton J, et al. Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function. PLoS ONE. 2019;14:e0216373 pubmed publisher

Zhang X, Liu L, Zhou S, Zhao K, Song Z, Hu G, et al. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas. Hematol Oncol. 2019;37:270-276 pubmed publisher

Meryk A, Pangrazzi L, Hagen M, Hatzmann F, Jenewein B, Jakic B, et al. Fcμ receptor as a Costimulatory Molecule for T Cells. Cell Rep. 2019;26:2681-2691.e5 pubmed publisher

Trinklein N, Pham D, Schellenberger U, Buelow B, Boudreau A, Choudhry P, et al. Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies. MAbs. 2019;11:639-652 pubmed publisher

Bröker K, Terzenbach R, Bentzien F, Lüth S, Dammermann W. Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity. J Transl Med. 2019;17:6 pubmed publisher

Aldeghaither D, Zahavi D, Murray J, Fertig E, Graham G, Zhang Y, et al. A Mechanism of Resistance to Antibody-Targeted Immune Attack. Cancer Immunol Res. 2019;7:230-243 pubmed publisher

Klement J, Paschall A, Redd P, Ibrahim M, Lu C, Yang D, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549-5560 pubmed publisher

Singh N, Sundar S. Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis. PLoS ONE. 2018;13:e0199817 pubmed publisher

Subramanian N, Wu Z, Reister F, Sampaio K, Frascaroli G, Cicin Sain L, et al. Naïve T cells are activated by autologous HCMV-infected endothelial cells through NKG2D and can control HCMV transmission in vitro. J Gen Virol. 2017;: pubmed publisher

Dammermann W, Dornbrack J, Bröker K, Bentzien F, Lüth S. CpG oligonucleotides increase HBV-specific cytokine responses in whole blood and enhance cytokine release assay sensitivity. J Virol Methods. 2017;248:195-201 pubmed publisher

Godbersen C, Coupet T, Huehls A, Zhang T, Battles M, Fisher J, et al. NKG2D Ligand-Targeted Bispecific T-Cell Engagers Lead to Robust Antitumor Activity against Diverse Human Tumors. Mol Cancer Ther. 2017;16:1335-1346 pubmed publisher

Singh N, Sundar S. Inflammatory chemokines and their receptors in human visceral leishmaniasis: Gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells. Mol Immunol. 2017;85:111-119 pubmed publisher

Kunyanee C, Kamjumphol W, Taweechaisupapong S, Kanthawong S, Wongwajana S, Wongratanacheewin S, et al. Burkholderia pseudomallei Biofilm Promotes Adhesion, Internalization and Stimulates Proinflammatory Cytokines in Human Epithelial A549 Cells. PLoS ONE. 2016;11:e0160741 pubmed publisher

Kilcollins A, Li J, Hsiao C, Wiemer A. HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by V?9V?2 T Lymphocyte Effectors. J Immunol. 2016;197:419-28 pubmed publisher

Karampetsou M, Comte D, Kis Toth K, Terhorst C, Kyttaris V, Tsokos G. Decreased SAP Expression in T Cells from Patients with Systemic Lupus Erythematosus Contributes to Early Signaling Abnormalities and Reduced IL-2 Production. J Immunol. 2016;196:4915-24 pubmed publisher

Wang E, Wang L, Tsai C, Bhoj V, Gershenson Z, Moon E, et al. Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors. Cancer Immunol Res. 2015;3:815-26 pubmed publisher

Wu Z, Sinzger C, Reichel J, Just M, Mertens T. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses. J Virol. 2015;89:2906-17 pubmed publisher

Ankrum J, Dastidar R, Ong J, Levy O, Karp J. Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids. Sci Rep. 2014;4:4645 pubmed publisher

Bendersky A, Marcu Malina V, Berkun Y, Gerstein M, Nagar M, Goldstein I, et al. Cellular interactions of synovial fluid ?? T cells in juvenile idiopathic arthritis. J Immunol. 2012;188:4349-59 pubmed publisher

Boggio E, Melensi M, Bocca S, Chiocchetti A, Comi C, Clemente N, et al. The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function. Hum Immunol. 2012;73:585-92 pubmed publisher

Zhang Y, Bliska J. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection. Infect Immun. 2010;78:2329-41 pubmed publisher

Ye Z, Lee C, Sun G, Gan Y. Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin. Infect Immun. 2008;76:2541-50 pubmed publisher